← All trials
NCT00535015
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2007
- Primary completion
- Jun 1, 2008
- Completion date
- Aug 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 70
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- AnaborexLead sponsor
- Univerisiti Sains MalaysiaOverall official - principal investigator
- Cathay General HospitalOverall official - principal investigator
- Taichung Veterans General HospitalOverall official - principal investigator
- University of MalayaOverall official - principal investigator
- Chung Shan Medical UniversityOverall official - principal investigator
- Changhua Christian HospitalOverall official - principal investigator
- University of AdelaideOverall official - principal investigator
- Hospital Pulau PinangOverall official - principal investigator
- Dharmais Cancer HospitalOverall official - principal investigator
- Gatot Subroto Central Army HospitalOverall official - principal investigator
- Tzu Chi General HospitalOverall official - principal investigator
- Taipei Medical UniversityOverall official - principal investigator
- City University of Hong KongOverall official - principal investigator
- Seoul National UniversityOverall official - principal investigator
- Catholic University of KoreaOverall official - principal investigator
- University of UlsanOverall official - principal investigator
- National Cheng Kung UniversityOverall official - principal investigator
- Tuen Mun Hospital, Hong KongOverall official - principal investigator
- Chimei Medical CenterOverall official - principal investigator
- China Medical UniversityOverall official - principal investigator
- Chang Gung UniversityOverall official - principal investigator
- The University of Hong KongOverall official - principal investigator
- Persahabatan General HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.